Simple jQuery Dropdowns

Browsing by Author Ali T. Taher

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)
1-Jan-2014Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: The safety profile of deferasiroxAli T. Taher; John B. Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Raffaella Origa; Zeynep Karakas; Dany Habr; Zewen Zhu; M. Domenica Cappellini; American University of Beirut; UCL; Mahidol University; University of Athens; King Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn University; Ospedale Regional Microcitemie; Istanbul Tip Fakultesi; Novartis Pharmaceuticals; Universita degli Studi di Milano
1-Jun-2013Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patientsAli T. Taher; John B. Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Renzo Galanello; Zeynep Karakas; Tomasz Lawniczek; Dany Habr; Jacqueline Ros; Yiyun Zhang; M. Domenica Cappellini; American University of Beirut Medical Center; UCL Cancer Institute; Mahidol University; University of Athens; Chulalongkorn University; Ospedale Regional Microcitemie; Istanbul Tip Fakultesi; Novartis International AG; Novartis Pharmaceuticals; Universita degli Studi di Milano
1-Nov-2013Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA studyAli T. Taher; John B. Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Renzo Galanello; Zeynep Karakas; Tomasz Lawniczek; Dany Habr; Jacqueline Ros; Zewen Zhu; M. Domenica Cappellini; American University of Beirut; UCL; Mahidol University; University of Athens; Chulalongkorn University; Universita degli Studi di Cagliari; Istanbul Tip Fakultesi; Novartis International AG; Novartis Pharmaceuticals; Universita degli Studi di Milano
2-Aug-2012Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-Year results from a prospective, randomized, double-blind, placebo-controlled studyAli T. Taher; John Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Renzo Galanello; Zeynep Karakas; Tomasz Lawniczek; Jacqueline Ros; Yiyun Zhang; Dany Habr; Maria Domenica Cappellini; American University of Beirut; UCL; Mahidol University; University of Athens; Chulalongkorn University; Universita degli Studi di Cagliari; Istanbul Tip Fakultesi; Novartis International AG; Novartis Pharmaceuticals; Universita degli Studi di Milano
11-Jan-2018Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a studyAli T. Taher; Zeynep Karakas; Elena Cassinerio; Noppadol Siritanaratkul; Antonis Kattamis; Aurelio Maggio; Stefano Rivella; Norbert Hollaender; Bruyere Mahuzier; Brian Gadbaw; Yesim Aydinok; American University of Beirut Medical Center; Università degli Studi di Milano; The Children's Hospital of Philadelphia; National and Kapodistrian University of Athens; Novartis Pharma S.A.S.; Istanbul Üniversitesi Tıp Fakültesi; Faculty of Medicine, Siriraj Hospital, Mahidol University; Novartis International AG; Ege University Medical School; Novartis Pharmaceuticals Corporation; UOSD MICI-A.O. Ospedali Riuniti “Villa Sofia-Cervello” Palermo
18-Jan-2013Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemiasVip Viprakasit; Norbert Gattermann; Jong Wook Lee; John B. Porter; Ali T. Taher; Dany Habr; Nicolas Martin; Gabor Domokos; Maria Domenica Cappellini; Mahidol University; Heinrich Heine Universitat; The Catholic University of Korea; UCL; American University of Beirut; Novartis Pharmaceuticals; Novartis International AG; Universita degli Studi di Milano
30-Sep-2014Identification and key management of non-transfusion-dependent thalassaemia patients: Not a rare but potentially under-recognised conditionVip Viprakasit; Paul Tyan; Sarayuth Rodmai; Ali T. Taher; Mahidol University; American University of Beirut Medical Center
1-Feb-2014Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): A status quoAli T. Taher; Khaled M. Musallam; Vip Viprakasit; John B. Porter; Maria Domenica Cappellini; American University of Beirut Medical Center; Mahidol University; UCL; Universita degli Studi di Milano
1-Jun-2018MRI for the diagnosis of cardiac and liver iron overload in patients with transfusion-dependent thalassemia: An algorithm to guide clinical use when availability is limitedVip Viprakasit; Amr Ajlan; Yesim Aydinok; Basim A.A. Al Ebadi; Hany Dewedar; Ahmed S. Ibrahim; Lamis Ragab; Omar Trad; Ahmed S. Wataify; Lily L.L. Wong; Ali T. Taher; University of Babylon; Tawam Hospital; American University of Beirut Medical Center; Kasr El-Aini School of Medicine; Ege Üniversitesi; Ain Shams University; Mahidol University; King Abdulaziz University; Basra Centre for Hereditary Blood Diseases; Dubai Health Authority; Queen Elizabeth Hospital
1-Mar-2016Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS studyAli T. Taher; M. Domenica Cappellini; Yesim Aydinok; John B. Porter; Zeynep Karakas; Vip Viprakasit; Noppadol Siritanaratkul; Antonis Kattamis; Candace Wang; Zewen Zhu; Victor Joaquin; Marie José Uwamahoro; Yong Rong Lai; American University of Beirut Medical Center; Università degli Studi di Milano; Ege University Medical School; UCL; Istanbul Tip Fakultesi; Mahidol University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; Guangxi Medical University
1-Jan-2014An overview of current treatment strategies for β-thalassemiaMaria Domenica Cappellini; Vip Viprakasit; Ali T. Taher; Universita degli Studi di Milano; Mahidol University; American University of Beirut
1-Jul-2018A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?Maria Domenica Cappellini; John B. Porter; Vip Viprakasit; Ali T. Taher; American University of Beirut Medical Center; Università degli Studi di Milano; UCL; Faculty of Medicine, Siriraj Hospital, Mahidol University
1-May-2013Treating iron overload in patients with non-transfusion-dependent thalassemiaAli T. Taher; Vip Viprakasit; Khaled M. Musallam; M. Domenica Cappellini; American University of Beirut Medical Center; Mahidol University; Universita degli Studi di Milano